Değertekin B, Demir M, Akarca US, Kani HT, Üçbilek E, Yıldırım E, et al. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology [Internet]. 2020 Jan. 12 [cited 2026 Jan. 1];31(12):883-9. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/3664